Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.01 (-1.40%)
Close on Nov 18, 2026Market cap $1.27MP/E –Yield –
Scinai Immunotherapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Scinai Immunotherapeutics's price to book ratio was 0.2× on Nov 11, 2026, against 2.0× a year earlier. Over the last 3 years it ranged from 0.2× to 312.3×, with a median of 2.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −1.1 |
| 2025 | Dec 31, 2025 | 1.4× | −9.9 |
| 2023 | Jan 31, 2023 | 11.3× | −1.5 |
| 2022 | Dec 30, 2022 | 12.8× | – |
See a number that looks wrong?